Novo Nordisk Sweetens Bid for Obesity Startup Metsera
Novo Nordisk A/S has again increased its offer for Metsera Inc., people familiar with the matter said, as its takeover battle with Pfizer Inc. for the obesity startup escalates.
By Michelle F Davis · Bloomberg Markets
Novo Nordisk A/S has again increased its offer for Metsera Inc., people familiar with the matter said, as its takeover battle with Pfizer Inc. for the obesity startup escalates.